AstraZeneca Pharma India Ltd. — Investor Relations & Filings
AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Shareholders meeting | 2018-09-11 | English | |
| Press Release | 2018-08-16 | English | |
| Shareholders meeting | 2018-08-14 | English | |
| AGM/Book Closure | 2018-08-14 | English | |
| Financial Result Updates | 2018-08-13 | English | |
| Press Release | 2018-08-09 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2018
15 filings
| |||||
| 43516460 | Shareholders meeting | 2018-09-11 | English | ||
| 43525891 | Press Release | 2018-08-16 | English | ||
| 43530375 | Shareholders meeting | 2018-08-14 | English | ||
| 43530597 | AGM/Book Closure | 2018-08-14 | English | ||
| 43551058 | Financial Result Updates | 2018-08-13 | English | ||
| 43534224 | Press Release | 2018-08-09 | English | ||
| 44047378 | Board Meeting — Financial Results | 2018-08-03 | English | ||
| 43545830 | Press Release | 2018-06-21 | English | ||
| 43553595 | Spurt in Volume | 2018-06-12 | English | ||
| 43553020 | Reply to Clarification- Financial results | 2018-05-24 | English | ||
| 43574909 | Outcome of Board Meeting | 2018-05-21 | English | ||
| 43575849 | Financial Result Updates | 2018-05-21 | English | ||
| 44049926 | Board Meeting — Financial Results | 2018-05-11 | English | ||
| 43562576 | Press Release | 2018-04-17 | English | ||
| 43568136 | Disc. under Reg.30 of SEBI (SAST) Reg.2011 | 2018-04-05 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
AstraZeneca Pharma India Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60656/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60656 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60656 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60656 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60656}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AstraZeneca Pharma India Ltd. (id: 60656)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.